Man Group plc

Position in RNAC — Cartesian Therapeutics, Inc.

CIK 1637460 LONDON, X0

Position in RNAC

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$145,748

-$124,166 QoQ

Shares Held

23,699

+266.1% QoQ

Ownership

0.078%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 92% Shared 0% None 8%

Healthcare · as of Jun 30, 2026

Man Group plc holds $1,100,351,284 across 114 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	436,956	$272,459,544
2	INCY	Incyte Corp	952,941	$108,025,391
3	ONC	BeOne Medicines Ltd.	307,463	$87,617,731
4	VRTX	Vertex Pharmaceuticals Inc / Ma	139,233	$69,161,207
5	APGE	Apogee Therapeutics, Inc.	397,000	$52,693,809
6	ALNY	Alnylam Pharmaceuticals, Inc.	170,907	$51,448,133
7	JAZZ	Jazz Pharmaceuticals plc	152,877	$36,838,770
8	RVMD	Revolution Medicines, Inc.	173,439	$32,481,655

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$145,748	23,699	-84.8%	Shares	Defined	2026-05-15
2023-03-31	$269,914	194,183	+311.3%	Principal	Defined	2023-05-15
2022-12-31	$176,486	156,183	+14.7%	Shares	Defined	2023-02-14
2022-09-30	$223,293	136,155	-24.4%	Shares	Sole	2022-11-14
2022-06-30	$61,841	47,208	—	Principal	Defined	2022-08-15
2021-12-31	$586,757	179,987	+0.3%	Shares	Defined	2022-02-14
2021-09-30	$746,266	179,391	+15.4%	Shares	Defined	2021-11-15
2021-06-30	$649,726	155,437	-26.7%	Shares	Defined	2021-08-16
2021-03-31	$959,964	212,147	-25.7%	Shares	Defined	2021-05-17
2020-12-31	$865,046	285,494	+21.3%	Shares	Defined	2021-02-16
2020-09-30	$583,831	235,416	+64.2%	Shares	Defined	2020-11-16
2020-06-30	$407,094	143,343	+271.1%	Shares	Defined	2020-08-14
2020-03-31	$93,081	38,623	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.